These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 25934888
1. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency. Yen WC, Fischer MM, Axelrod F, Bond C, Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, Tang T, Wallace B, Wang M, Zhang C, Kapoun AM, Lewicki J, Gurney A, Hoey T. Clin Cancer Res; 2015 May 01; 21(9):2084-95. PubMed ID: 25934888 [Abstract] [Full Text] [Related]
2. EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency. Fu W, Lei C, Yu Y, Liu S, Li T, Lin F, Fan X, Shen Y, Ding M, Tang Y, Ye X, Yang Y, Hu S. Clin Cancer Res; 2019 May 01; 25(9):2835-2847. PubMed ID: 30670492 [Abstract] [Full Text] [Related]
3. A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors. Smith DC, Chugh R, Patnaik A, Papadopoulos KP, Wang M, Kapoun AM, Xu L, Dupont J, Stagg RJ, Tolcher A. Invest New Drugs; 2019 Aug 01; 37(4):722-730. PubMed ID: 30591982 [Abstract] [Full Text] [Related]
5. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy. Hayashi T, Gust KM, Wyatt AW, Goriki A, Jäger W, Awrey S, Li N, Oo HZ, Altamirano-Dimas M, Buttyan R, Fazli L, Matsubara A, Black PC. Clin Cancer Res; 2016 Jun 15; 22(12):2981-92. PubMed ID: 26769750 [Abstract] [Full Text] [Related]
10. The role of Notch receptor expression in bile duct development and disease. Flynn DM, Nijjar S, Hubscher SG, de Goyet Jde V, Kelly DA, Strain AJ, Crosby HA. J Pathol; 2004 Sep 01; 204(1):55-64. PubMed ID: 15307138 [Abstract] [Full Text] [Related]
11. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis. Ruan ZB, Fu XL, Li W, Ye J, Wang RZ, Zhu L. Biomed Pharmacother; 2016 Dec 01; 84():666-673. PubMed ID: 27697639 [Abstract] [Full Text] [Related]
12. [Effect of Notch1, 2, 3 genes silencing on Notch and nuclear factor-κB signaling pathway of macrophages derived from patients with coronary artery disease]. Ruan ZB, Fu XL, Li W, Ye J, Wang RZ, Yin YG, Zhu L. Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep 24; 44(9):786-792. PubMed ID: 27667278 [Abstract] [Full Text] [Related]
13. Notch2 and Notch3 function together to regulate vascular smooth muscle development. Wang Q, Zhao N, Kennard S, Lilly B. PLoS One; 2012 Sep 24; 7(5):e37365. PubMed ID: 22615991 [Abstract] [Full Text] [Related]
18. Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells. Baeten JT, Lilly B. J Biol Chem; 2015 Jun 26; 290(26):16226-37. PubMed ID: 25957400 [Abstract] [Full Text] [Related]
19. Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines. Zhao WX, Zhuang X, Huang TT, Feng R, Lin JH. Int J Med Sci; 2015 Jun 26; 12(11):867-74. PubMed ID: 26640406 [Abstract] [Full Text] [Related]
20. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells. Pastò A, Serafin V, Pilotto G, Lago C, Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G, Pinazza M, Agostini M, Nitti D, Amadori A, Indraccolo S. Cancer Res; 2014 Apr 01; 74(7):2106-18. PubMed ID: 24525742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]